Invention Grant
- Patent Title: Aza-heteroaryl compounds as PI3K-gamma inhibitors
- Patent Title (中): 氮杂杂芳基化合物作为PI3K-γ抑制剂
-
Application No.: US15019144Application Date: 2016-02-09
-
Publication No.: US09586949B2Publication Date: 2017-03-07
- Inventor: Ge Zou , Andrew P. Combs , Andrew W. Buesking
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D413/04
- IPC: C07D413/04 ; C07D401/14 ; C07D413/14 ; C07D417/14 ; C07D471/04
Abstract:
The present invention provides aza-heteroaryl derivatives of Formula I: and pharmaceutically acceptable salts thereof, wherein X, Y, Z, A, W, R4, R5, and R6 are defined herein, that inhibit the activity of phosphoinositide 3-kinases-gamma (PI3Kγ) and are useful in the treatment of diseases related to the activity of PI3Kγ including, for example, autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
Public/Granted literature
- US20160229843A1 AZA-HETEROARYL COMPOUNDS AS PI3K-GAMMA INHIBITORS Public/Granted day:2016-08-11
Information query
